Revathi Rammohan

Advisory Board Member @ International Vaccine Institute (IVI)

About

C level executive with 35+ years track record in life sciences industry, with expertise in areas of strategy, operational excellence, business development & licensing, governance, resource allocation, risk management and audit. Proven track record of consistently delivering superior financial results. Developing and executing strategy, building and delivering financials, partnering externally for many collaborations with Biotech, VCs and Academia. Instrumental in establishing and creating a blueprint for launch of Novartis global shared services organization. International experience with senior leadership roles both at country and global level across many cultures – Asia, Africa, Europe and US. Oversight of Finance, Procurement, Real Estate, Facilities and Scientific Operations. Passion for D&EI and talent development.

Country

United States

City

Cambridge

Industry

Pharmaceuticals

Skill

Experience

Advisory Board Member

International Vaccine Institute (IVI)

2024-9 - Present · 2 yrs 1 mo

CFO and Head Research Operations

Novartis

2019-7 - 2023-2 · 3 yrs 8 mos

Cambridge, Massachusetts

CFO

Novartis

2017-7 - 2019-6 · 2 yrs

Cambridge, Massachusetts

CFO for NIBR an organization of ~ 6000 research scientists, physicians and business professionals focused on pushing the boundaries of science to change the practice of medicine

CFO, Novartis Business Services

Novartis

2014-5 - 2017-6 · 3 yrs 2 mos

Basel Area, Switzerland

Enabled the set up and operationalization of new shared services organization managing ~ $5bn in spend and ~10000 associates in 200 legal entities. Scope included IT, Real Estate, HR, Accounting, Procurement and Commercial/Medical Services. Delivered significant productivity savings, partnering to drive transformation plans including restructuring and footprint plans. Delivering high quality services while driving efficiency, simplification and standardization.

Head Global Business Planning/Analysis and Financial Operations

Novartis Pharma AG

2013-7 - 2014-4 · 10 mos

Basel, Switzerland

Led financial planning & budgeting process for Innovative Medicines Division of ~ $30bn in sales, driving resource allocation, managing risks and opportunities by anticipating business trends, recommending plans for course correction and ensuring financial objectives are met

Country Chief Financial Officer, Spain

Novartis

2011-1 - 2013-6 · 2 yrs 6 mos

Driving business performance, cash flow and strategic planning for a business of $1bn sales. Responsible for Corporate Finance, Tax, Treasury across 6 divisions and 4 manufacturing units. Managed outstanding government receivables in Euro crisis environment, negotiating key factoring deals. Financial oversight of several co-marketing/co-promotion deals

Vice President Finance - North America

Novartis

2008-2 - 2010-12 · 2 yrs 11 mos

Greater New York City Area

Finance head for North American Oncology business. Enabled USA Oncology growth strategy supported by pricing strategy, new specialty distribution agreements, field force sizing, portfolio management of development projects and resource allocation

Executive Director Specialty Medicines BPA

Novartis

2004-8 - 2009-12 · 5 yrs 5 mos

Responsible for providing financial and strategic counsel on key business, resource allocation and investment decision to the President of Oncology and VP of Oncology Finance. Challenge risks and opportunities, review & analyze the global financial results of the BU.

SAP Finance Domain Lead

Novartis

2003-2 - 2004-7 · 1 yr 6 mos

Drove global implementation of SAP financial systems including BW in ~ 50 countries, delivering all projects on time, to cost and quality, ensuring significant process improvements. - Defining and integrating Finance Standards and processes in the Global SAP roll out

SAP UK Project Manager

Novartis

1999-3 - 2003-1 · 3 yrs 11 mos

Set up SAP global core financial system. Project Manager for pilot in UK – first Commercial followed by Manufacturing, delivering significant benefits through change management, stakeholder management and leading cultural change.